New Delhi, India; Mumbai, India 7/25/07­—Indian news sources report that RFCL, an Indian supplier of laboratory products and services, has acquired Wipro Biomed, an OEM partner and distributor of research and clinical products, from software company Wipro. The transaction price was not disclosed. Wipro Biomed consists of three businesses: the Life Science Group, Diagnostic System Group and Medical Systems Group. RFCL, which is owned by Indian private equity firm ICICI Ventures, operates four businesses: Rankem (scientific laboratory solutions), Diagnova (diagnostics), Vetnex (animal health care) and NeoSynth (custom synthesis). The Hindu Business Line quoted a press release in which RFCL Managing Director Sushil Mehta commented, “This acquisition will enable RFCL to enter into the high growing segments of in vivo diagnostics, fully automated clinical chemistry and hematology, and research solutions. Together with BioMed, RFCL will be able to achieve critical mass and emerge as key player in the $375 million market which is growing at a rate of 15% per annum.”